0ed6c856 4d95 4aeb B925 15346555a2ab 565 2
Topiramate Tablet, Film Coated
Product Images NDC 50090-2102
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50090-2102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
9df497de Be9f 4244 A769 A72a0e64dc42 01
9df497de Be9f 4244 A769 A72a0e64dc42 02
This text provides information about cumulative rates for time to the first seizure. It suggests that the rates vary based on the dosage of Topiramate, with two dosages mentioned - 50 mg/day and 400 mg/day. The text also includes a statistical value (p=0.0002) indicating a significant difference between the two dosage groups. Additionally, a graph or chart is likely referenced, showing time (in days) on the x-axis and cumulative rates on the y-axis.*
9df497de Be9f 4244 A769 A72a0e64dc42 03
Label Image (Lbl500902102)
Label Image (Lbl500902203)
This is a product description for a medicine labeled "6138-0". It appears to be a tablet with a dosage of 50 MG. The text also mentions the presence of "Stone AT a7 vecaces ยข". However, due to the unclear nature of the text, the full description cannot be accurately determined.*
Label Image (Lbl500902248)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
